大成食品(03999.HK):2021年全年純利1.55億元,同比下降23.4%
格隆匯3月24日丨大成食品(03999.HK)公佈2021年全年業績,2021年實現經營收入人民幣65.309億元,同比增長6.2%;毛利6.618億元,同比下降7.3%;公司股東應占溢利1.55億元,同比下降23.4%;基本每股盈利0.15元。
2021年,集團應對嚴峻複雜的國內外經濟環境,不盲目追求規模擴張,但採取穩定發展的策略。股東應占溢利儘管同比下降約23.4%,但獲利仍達至約1.55億元,業績為近十年次高。獲利同比出現下滑的主要因素是東南亞和日本市場經濟增長乏力,以及國內畜禽行情低迷,導致東南亞飼料事業、食品事業對日出口業務和肉品事業獲利下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.